White House reviews Trump’s revived drug pricing rule
President Trump has set a Sept. 29 deadline for pharma companies to align U.S. prices with global benchmarks, warning of regulatory action if they don't comply.
CMS
President Trump has set a Sept. 29 deadline for pharma companies to align U.S. prices with global benchmarks, warning of regulatory action if they don't comply.